Coalition opposes comparative-effectiveness provision

02/9/2009 | Wall Street Journal, The

The Partnership to Improve Patient Care, a coalition that represents the drug, medical-device and biotech sectors, is seeking to remove a provision in the U.S. House's version of the stimulus bill that would allot $1.1 billion for comparative-effectiveness studies. Such research might be used "in an inappropriate manner that may limit treatment options for patients," said David Di Martino, a spokesman for the coalition.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN